- $51.65bn
- $75.21bn
- $6.98bn
- 62
- 32
- 85
- 61
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,763 | 5,840 | 6,340 | 6,986 | 6,981 |
Cost of Revenue | |||||
Gross Profit | 3,777 | 3,871 | 4,347 | 4,918 | 5,001 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,206 | 4,072 | 4,484 | 4,589 | 4,612 |
Operating Profit | 1,557 | 1,768 | 1,856 | 2,397 | 2,369 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 881 | 1,076 | 1,179 | 1,691 | 1,528 |
Provision for Income Taxes | |||||
Net Income After Taxes | 860 | 1,056 | 1,158 | 1,675 | 1,502 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 860 | 1,056 | 1,096 | 1,675 | 1,502 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 747 | 999 | 1,096 | 1,675 | 1,502 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.87 | 2.76 | 3.05 | 4.01 | 3.73 |
Dividends per Share |